Abstract
We use diffuse correlation spectroscopy to safely quantify cerebral blood flow response to spontaneous fluctuations in autonomic and respiratory activities to help characterize the elevated risk of intraventricular hemorrhage in extremely premature newborns.
Original language | English |
---|---|
Title of host publication | Clinical and Translational Biophotonics, Translational 2020 |
Publisher | OSA - The Optical Society |
ISBN (Electronic) | 9781557528209 |
Publication status | Published - 2020 |
Event | Clinical and Translational Biophotonics, Translational 2020 - Washington, United States Duration: 20 Apr 2020 → 23 Apr 2020 |
Publication series
Name | Optics InfoBase Conference Papers |
---|---|
Volume | Part F178-Translational-2020 |
Conference
Conference | Clinical and Translational Biophotonics, Translational 2020 |
---|---|
Country/Territory | United States |
City | Washington |
Period | 20/04/20 → 23/04/20 |
Bibliographical note
Funding Information:This work is supported by NIH 1R01HD095576-01A1. MAF has a financial interest in 149 Medical, Inc., a company developing DCS technology for assessing and monitoring cerebral blood flow in newborn infants, and in Dynometrics, Inc., a company that makes devices that use NIRS technology for athletes to evaluate muscle performance. MAF’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.
Publisher Copyright:
© OSA 2020 © 2020 The Author(s)
ASJC Scopus subject areas
- Mechanics of Materials
- Electronic, Optical and Magnetic Materials